What Is Kisspeptin? Dosage, Half-Life & How to Track It

What kisspeptin is and how it works

Kisspeptin is the signal that sits at the very top of the reproductive hormone cascade. KISS1 neurons in the hypothalamus release it, it binds the GPR54 receptor (also called KISS1R) on GnRH neurons, and that triggers the pulsatile GnRH release that then tells the pituitary to secrete LH and FSH. In other words: kisspeptin → GnRH → LH/FSH → testosterone or estrogen — one level upstream of even gonadorelin (synthetic GnRH).

That position gives it a distinct research profile. Because KISS1 neurons integrate signals like nutritional status and leptin, kisspeptin is studied as the biological link between metabolic state and reproductive function — part of why, for example, severe caloric deficit or low body fat can suppress the whole axis. It’s also studied clinically at legitimate academic centers, notably for IVF triggering and hypothalamic amenorrhea, not purely as a research-peptide community compound.

One curiosity worth knowing: kisspeptin was first identified as a metastasis-suppressor gene product (hence “metastin”) before its reproductive role was discovered — an unrelated finding that gave it its alternate name.

Typical dosing & reconstitution

Community protocols use a conservative once-daily titration — 100 mcg for the first couple of weeks, then 200 mcg for the following weeks, typically run over 8–12 weeks. There’s no clinical dosing standard for subcutaneous self-use; the clinical research on kisspeptin (IVF triggering, amenorrhea studies) uses IV infusion protocols that don’t translate directly to a daily subcutaneous shot.

Kisspeptin comes as a lyophilized powder:

At 3.33 mg/mL, a 100 mcg dose is 3 units and 200 mcg is 6 units on a U-100 insulin syringe. Store the lyophilized vial frozen and the reconstituted solution refrigerated, protected from light.

Half-life & what it means for frequency

Kisspeptin-10 clears the bloodstream in about 4 minutes — even faster than gonadorelin, and among the shortest half-lives of any peptide covered here. Clinical research infusing it intravenously does so continuously, over hours, specifically to compensate for how fast it disappears otherwise.

That mismatch is worth sitting with: a once-daily subcutaneous injection delivers a brief spike that’s gone within minutes, a very different exposure pattern from the sustained IV infusions used in the studies that actually demonstrate its effects on LH/FSH release.

What to track & common side effects

Reported side effects at research-peptide doses are generally mild — injection-site reactions, occasional flushing or headache. Because it sits upstream of the same axis as gonadorelin and hCG, hormone-related effects (mood, libido changes) would trace to the same downstream testosterone or estrogen shifts.

Given how early-stage the self-dosing use case is, what’s worth tracking is the basics: the daily streak (it’s easy to let a once-daily peptide slip), and whatever outcome you’re actually testing for — energy, libido, or labs if your prescriber is checking LH/FSH/testosterone.

Frequently asked questions